Psychemedics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch Psychemedics and buy or sell other stocks, ETFs, and their options commission-free!

About PMD

Psychemedics Corp. engages in the provision of drug testing services through the analysis of hair samples. It specializes in a five panel drug testing process for cocaine, opioids, Phenyclidine, amphetamines, and marijuana. 

CEO
Brian Hullinger
CEOBrian Hullinger
Employees
Employees
Headquarters
Dallas, Texas
HeadquartersDallas, Texas
Founded
1986
Founded1986
Employees
Employees

PMD Key Statistics

Market cap
15.24M
Market cap15.24M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
2.22K
Average volume2.22K
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$2.70
52 Week high$2.70
52 Week low
$1.33
52 Week low$1.33

Stock Snapshot

Psychemedics(PMD) stock is priced at $2.49, giving the company a market capitalization of 15.24M.

Psychemedics(PMD) stock opened on 2026-07-08 at —. The price climbed to — and dipped to —.

The Psychemedics(PMD)'s current trading volume is 0, compared to an average daily volume of 2.22K.

In the last year, Psychemedics(PMD) shares hit a 52-week high of $2.70 and a 52-week low of $1.33.

In the last year, Psychemedics(PMD) shares hit a 52-week high of $2.70 and a 52-week low of $1.33.

People also own

Based on the portfolios of people who own PMD. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.